Promoter methylation of BRCA1 is associated with estrogen, progesterone and human epidermal growth factor receptornegative tumors and the prognosis of breast cancer: A meta-analysis

By              

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1353-1360

Science Publishers

Access to resources Recommend Favorite

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

By Neibergs Holly  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 59-60

Informa Healthcare

Access to resources Recommend Favorite

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations

By Steffensen Ane   Jønson Lars   Ejlertsen Bent   Gerdes Anne-Marie   Nielsen Finn   Hansen Thomas  

Familial Cancer, Vol. 9, Iss. 3, 2010-09 ,pp. : 283-287

Springer Publishing Company

Access to resources Recommend Favorite

BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families

By Peixoto Ana   Salgueiro Natália   Santos Catarina   Varzim Graça   Rocha Patrícia   Soares Maria   Pereira Deolinda   Rodrigues Helena   Bento Maria   Fráguas António   Moura Graça   Regateiro Fernando   Castedo Sérgio   Teixeira Manuel  

Familial Cancer, Vol. 5, Iss. 4, 2006-11 ,pp. : 379-387

Springer Publishing Company

Access to resources Recommend Favorite

Relative contributions of BRCA1 and BRCA2 mutations to “triple-negative” breast cancer in Ashkenazi Women

By Comen E.   Davids M.   Kirchhoff T.   Hudis C.   Offit K.   Robson M.  

Breast Cancer Research and Treatment, Vol. 129, Iss. 1, 2011-08 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite